Structure Therapeutics (GPCR) Return on Assets [ROA] (2023 - 2026)
Structure Therapeutics (GPCR) recorded Return on Assets [ROA] of -14.65% in Q2 2026, up 6.62 percentage points from -21.27% a year earlier but down 3.63 percentage points from the prior quarter.
Powered by 
Analysis
Structure Therapeutics (GPCR) Return on Assets [ROA] (2023 - 2026) Analysis & Trends
For FY2025, Structure Therapeutics reported Return on Assets [ROA] of -11.35%, up 6.33 percentage points from FY2024.
- Across earlier years, Return on Assets [ROA] came in at -17.69% in FY2024 (+13.22 pp) and -30.91% in FY2023.
- Quarterly Return on Assets [ROA] has ranged from -34.54% in Q3 2023 to -11.02% in Q1 2026 over the past five years.
- On a year-over-year basis, Return on Assets [ROA] has increased for three consecutive quarters, with an average year-over-year change of +4.05 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 22.78 percentage points in Q3 2024, against a drop of 13.80 percentage points in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -11.02% (Q1 2026), -11.69% (Q4 2025) and -25.56% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 2.14% |
| 10 | Structure Therapeutics | 4.69 Bn | 3.34 Bn | - | -14.65% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14.65% |
| Mar 31, 2026 | -11.02% |
| Dec 31, 2025 | -11.69% |
| Sep 30, 2025 | -25.56% |
| Jun 30, 2025 | -21.27% |
| Mar 31, 2025 | -16.20% |
| Dec 31, 2024 | -13.34% |
| Sep 30, 2024 | -11.76% |
| Jun 30, 2024 | -14.30% |
| Mar 31, 2024 | -20.80% |
| Dec 31, 2023 | -25.66% |
| Sep 30, 2023 | -34.54% |
| Jun 30, 2023 | -27.50% |
| Mar 31, 2023 | -32.57% |
API Access
Structure Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GPCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "GPCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GPCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();